Pharmaceutical Industry Information Portal

HomeNews

News

GMP-inspections of veterinary manufacturers in the fourth quarter of 2023

This review provides information on the inspection of manufacturers of veterinary medicines for compliance with the requirements of the Good Manufacturing Practice (GMP) which is carried out by specialists of the Federal State Budgetary Institution "The All-Russian State Center for Quality and Standardization of Veterinary Drugs and Feed" (FSBI "VGNKI").

GMP-inspections of veterinary manufacturers in the third quarter of 2023

This review provides information on the inspection of manufacturers of veterinary medicines for compliance with the GMP Rules requirements which is carried out by specialists of the Federal State Budgetary Institution "The All-Russian State Center for Quality and Standardization of Veterinary Drugs and Feed" (FSBI "VGNKI").

Pharmaceutical Drug Production in Russia (June, January–June 2023)

In January–June 2023, Russian manufacturers produced 342.5 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 2.6% from the same period in 2022.

Production of one of the world’s most sought-after drugs for migraine therapy starts in Moscow

The Russian pharmaceutical company NovaMedica has announced the production and market launch of the first large batch of the drug Relonova® intended for relief of migraine-associated headaches.

GMP-inspections of veterinary manufacturers in the second quarter of 2023

There are only two months left before the amendments to Federal Law No. 61-FZ of 12.04.2010 "On the Circulation of Medicines" introduced by Federal...

RNC Pharma: Pharmaceutical Drug Production in Russia (May 2023)

In January–May 2023, Russian manufacturers produced 282 billion rubles’ of pharmaceutical drugs (manufacturer’s prices, VAT included), down 5.8% from the same period in 2022.
spot_img

Expert Articles

spot_img